Literature DB >> 24436885

Predictive factors for vision recovery after optic nerve decompression for chronic compressive neuropathy: systematic review and meta-analysis.

Andrew P Carlson1, Martina Stippler1, Orrin Myers2.   

Abstract

Objectives Surgical optic nerve decompression for chronic compressive neuropathy results in variable success of vision improvement. We sought to determine the effects of various factors using meta-analysis of available literature. Design Systematic review of MEDLINE databases for the period 1990 to 2010. Setting Academic research center. Participants Studies reporting patients with vision loss from chronic compressive neuropathy undergoing surgery. Main outcome measures Vision outcome reported by each study. Odds ratios (ORs) and 95% confidence intervals (CIs) for predictor variables were calculated. Overall odds ratios were then calculated for each factor, adjusting for inter study heterogeneity. Results Seventy-six studies were identified. Factors with a significant odds of improvement were: less severe vision loss (OR 2.31[95% CI = 1.76 to 3.04]), no disc atrophy (OR 2.60 [95% CI = 1.17 to 5.81]), smaller size (OR 1.82 [95% CI = 1.22 to 2.73]), primary tumor resection (not recurrent) (OR 3.08 [95% CI = 1.84 to 5.14]), no cavernous sinus extension (OR 1.88 [95% CI = 1.03 to 3.43]), soft consistency (OR 4.91 [95% CI = 2.27 to 10.63]), presence of arachnoid plane (OR 5.60 [95% CI = 2.08 to 15.07]), and more extensive resection (OR 0.61 [95% CI = 0.4 to 0.93]). Conclusions Ophthalmologic factors and factors directly related to the lesion are most important in determining vision outcome. The decision to perform optic nerve decompression for vision loss should be made based on careful examination of the patient and realistic discussion regarding the probability of improvement.

Entities:  

Keywords:  optic nerve; optic nerve decompression; skull base meningioma; skull base surgery; vision loss

Year:  2012        PMID: 24436885      PMCID: PMC3699164          DOI: 10.1055/s-0032-1329624

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  87 in total

1.  Transsphenoidal management of 28 symptomatic Rathke's cleft cysts, with special reference to visual and hormonal recovery.

Authors:  W el-Mahdy; M Powell
Journal:  Neurosurgery       Date:  1998-01       Impact factor: 4.654

2.  Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale: surgical results with special consideration of ophthalmological and endocrinological outcomes.

Authors:  Rudolf Fahlbusch; Werner Schott
Journal:  J Neurosurg       Date:  2002-02       Impact factor: 5.115

3.  Five-year follow-up of nonsecreting pituitary adenomas.

Authors:  B Petruson; K E Jakobsson; J Elfverson; B A Bengtsson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-03

4.  Ophthalmic manifestations of paranasal sinus mucocoeles.

Authors:  S Ahmed Sadiq; M Kim Lim; Nicholas S Jones
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

5.  Tuberculum sellae meningioma: a report on management on the basis of a surgical experience with 70 patients.

Authors:  Atul Goel; Dattatraya Muzumdar; Ketan I Desai
Journal:  Neurosurgery       Date:  2002-12       Impact factor: 4.654

6.  Medial sphenoid ridge meningiomas: classification, microsurgical anatomy, operative nuances, and long-term surgical outcome in 35 consecutive patients.

Authors:  Stephen M Russell; Vallo Benjamin
Journal:  Neurosurgery       Date:  2008-03       Impact factor: 4.654

7.  Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children.

Authors:  Robert E Elliott; Kevin Hsieh; Tsivia Hochm; Ilana Belitskaya-Levy; Jessica Wisoff; Jeffrey H Wisoff
Journal:  J Neurosurg Pediatr       Date:  2010-01       Impact factor: 2.375

8.  Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography.

Authors:  Maud Jacob; Gérald Raverot; Emmanuel Jouanneau; Françoise Borson-Chazot; Gilles Perrin; Muriel Rabilloud; Caroline Tilikete; Martine Bernard; Alain Vighetto
Journal:  Am J Ophthalmol       Date:  2008-09-06       Impact factor: 5.258

9.  Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968-1987.

Authors:  L J Sullivan; J O'Day; P McNeill
Journal:  J Clin Neuroophthalmol       Date:  1991-12

10.  Meta-analysis: neither quick nor easy.

Authors:  Nancy G Berman; Robert A Parker
Journal:  BMC Med Res Methodol       Date:  2002-08-09       Impact factor: 4.615

View more
  6 in total

1.  Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.

Authors:  S Hisanaga; S Kakeda; J Yamamoto; K Watanabe; J Moriya; T Nagata; Y Fujino; H Kondo; S Nishizawa; Y Korogi
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

2.  Transorbital Endoscopic Surgery for Sphenoid Wing Meningioma: Long-Term Outcomes and Surgical Technique.

Authors:  N Goncalves; D E Lubbe
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-20

3.  Optic nerve sheath diameters in healthy adults measured by computer tomography.

Authors:  Michael Vaiman; Rani Abuita; Inessa Bekerman
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

4.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

5.  The Role of Endonasal Endoscopic Optic Nerve Decompression as the Initial Management of Primary Optic Nerve Sheath Meningiomas.

Authors:  Guillermo Maza; Somasundaram Subramaniam; Juan C Yanez-Siller; Bradley A Otto; Daniel M Prevedello; Ricardo L Carrau
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-10

Review 6.  Complete recovery of visual disorder following surgical resection of adenoid cystic carcinoma arising in the pterygopalatine fossa: case report and review of the literature.

Authors:  Wei Du; Meng Cui; Peng Li; Jiheng Wang; Ruihua Luo; Jinxing Qi; Ming Zhao; Weihua Lou
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.